China Develops Booster Shots For Less Effective Sinopharm, Sinovac COVID-19 Vaccines
KEY POINTS
The booster vaccine has been reviewed by Chinese drug regulators
Talks about the booster shot came after studies found that China-manufactured vaccines produced lower antibody levels
China may be developing a booster shot for people who have been fully vaccinated against COVID-19 with the arguably less effective jabs of Sinopharm and Sinovac.
China’s Shanghai Fosun Pharmaceutical (Fosun Pharma) has partnered with BioNTech to develop an mRNA booster vaccine. The shot is now in the administrative review stage following an expert panel review conducted by Chinese drug regulators, Caixin Global reported.